Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells-Reference-Cited by-同舟云学术

Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells

Published:2018-01 Issue: Volume:54 Page:39-45
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Homma Sadamu,Hayashi Kazumi,Yoshida Kosaku,Sagawa Yukiko,Kamata Yuko,Ito Masaki

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference37 articles.

1. Evolving concepts: immunity in oncology from targets to treatments;Khan;J. Oncol.,2015

2. The evolving role of nivolumab in non-small-cell lung cancer for second-line treatment: a new cornerstone for our treatment algorithms. Results from an international experts panel meeting of the italian association of thoracic oncology;Gridelli;Clin. Lung Cancer,2016

3. The expanding role of immunotherapy in melanoma—introduction;Agarwala;Semin. Oncol.,2015

4. Neoantigens in cancer immunotherapy;Schumacher;Science,2015

5. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial;Seiwert;Lancet Oncol.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCT‐Mediated Process for the Preparation of Nafamostat Mesylate and Camostat Mesylate;ChemistrySelect;2023-05-10

2. Inhibition of Listeria Monocytogenes HtrA Protease with Camostat, Gabexate and Nafamostat Mesylates and the Binding Mode of the Inhibitors;The Protein Journal;2023-04-24

3. The Rabep1-Mediated Endocytosis and Activation of Trypsinogen to Promote Pancreatic Stellate Cell Activation;Biomolecules;2022-07-31

4. Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins;Antiviral Research;2022-06

5. Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?;Frontiers in Immunology;2022-03-15